Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensis

• Published in: Infection and immunity 2019-08, Vol.87 (8)
• Main Authors: O'Malley, Katherine J, Bowling, Jennifer D, Barry, Eileen M, Hazlett, Karsten R O, Reed, Douglas S
• Format: Article
• Language: English
• Subjects: Aerosols; Animals; Bacterial Infections; Bacterial Vaccines - immunology; Depsipeptides; Disease Models, Animal; Female; Francisella tularensis - immunology; Inhalation Exposure; Male; Particle Size; Rabbits; Reproducibility of Results; Tularemia - etiology; Tularemia - mortality; Tularemia - physiopathology; Vaccination
• ISSN: 0019-9567; 1098-5522
• DOI: 10.1128/IAI.00198-19

Inhalation of causes pneumonic tularemia in humans, a severe disease with a 30 to 60% mortality rate. The reproducible delivery of aerosolized virulent bacteria in relevant animal models is essential for evaluating medical countermeasures. Here we developed optimized protocols for infecting New Zealand White (NZW) rabbits with aerosols containing We evaluated the relative humidity, aerosol exposure technique, and bacterial culture conditions to optimize the spray factor (SF), a central metric of aerosolization. This optimization reduced both inter- and intraday variability and was applicable to multiple isolates of Further improvements in the accuracy and precision of the inhaled pathogen dose were achieved through enhanced correlation of the bacterial culture optical density and the number of CFU. Plethysmograph data collected during exposures found that respiratory function varied considerably between rabbits, was not a function of weight, and did not improve with acclimation to the system. Live vaccine strain (LVS)-vaccinated rabbits were challenged via aerosol with human-virulent SCHU S4 that had been cultivated in either Mueller-Hinton broth (MHB) or brain heart infusion (BHI) broth. LVS-vaccinated animals challenged with SCHU S4 that had been cultivated in MHB experienced short febrile periods (median, 3.2 days), limited weight loss (10%) than the unvaccinated controls and median survival times that were not significantly different from those for the unvaccinated controls. These studies highlight the importance of careful characterization and optimization of protocols for aerosol challenge with pathogenic agents.